Recent testing by the Trump administration revealed that many baby formula samples contained harmful chemicals, including Pfas and phthalates, despite claims of safety. Public health advocates argue that these findings contradict the administration's assertions, emphasizing that even low levels of these toxic substances can pose serious health risks to newborns. The U.S. Food and Drug Administration (FDA) conducted tests under Operation Stork Speed, which examined 300 samples for various contaminants. While some results were praised, concerns remain about the prevalence of endocrine-disrupting chemicals, which can affect children's hormonal development. Experts also noted significant gaps in the FDA's data, including a lack of product identification and the potential for multiple contaminants in single samples. The FDA reported that 95% of Pfas levels were below 2.9 parts per trillion, but advocates argue that these limits may not adequately protect infants. Calls for increased transparency and legislative action are mounting, as industry testing remains largely unregulated. The FDA's next steps involve establishing action levels for lead and other contaminants in baby formulas, which currently lack enforceable limits.